New editorial urges clinicians to address sex-based disparities in sepsis treatment
The editorial highlights biological and gender-driven disparities shaping antibiotic dosing, therapeutic effectiveness, and outcomes in sepsis treatment
2025-10-31
(Press-News.org)
Sepsis continues to be a leading cause of mortality in ICUs worldwide. Despite advances in early detection and treatment, standardized antibiotic dosing frequently ignores patient-level variability—especially that associated with sex-related physiology and gender-influenced care disparities.
A newly published editorial in the Journal of Intensive Medicine on September 8, 2025, is calling attention to how biological sex and gender inequities contribute to suboptimal sepsis treatment, potentially compromising outcomes for women. Authored by Dr. Helena Barrasa, Dr. Goiatz Balziskueta, and Prof. Jordi Rello, the piece highlights overlooked pharmacokinetic and pharmacodynamic differences between men and women, and urges the integration of sex and gender into antimicrobial dosing protocols.
The editorial emphasizes that women often face both underrepresentation in pharmacological trials and higher risks of antibiotic overexposure. Hormonal fluctuations, body composition, and renal clearance all influence how drugs are processed, yet these variables are rarely considered in dosing algorithms. Meanwhile, men—especially younger individuals with augmented renal clearance—may be underdosed, leading to treatment failure.
"Standard dosing overlooks key biological differences," said the authors. "Women, due to altered metabolism and lower muscle mass, are more vulnerable to adverse effects, while young men often eliminate drugs too quickly to maintain therapeutic levels."
Beyond biology, gender roles and biases further complicate sepsis care. Women are less likely than men to receive aggressive or timely interventions, with disparities stemming from symptom misinterpretation, healthcare-seeking behaviors, or implicit bias within emergency systems.
These inequities compound the biological differences already influencing pharmacokinetics and pharmacodynamics. Standardized dosing often overlooks how women are more prone to antibiotic overexposure and adverse reactions, while younger men with augmented renal clearance face underdosing and treatment failure. Such imbalances highlight the urgency of tailoring antimicrobial therapy more precisely.
The authors advocate for wider use of therapeutic drug monitoring to individualize treatment and reduce both toxicity and resistance. They also call on the scientific community to integrate sex- and gender-aware research protocols, noting that fewer than 30% of studies currently report sex-stratified data.
In conclusion, Prof. Rello stated, "Understanding the differences shaped by sex and gender is essential to advancing personalized medicine and represents a commitment to reducing the equity gap."
***
Reference
DOI: 10.1016/j.jointm.2025.08.004
About Vall d'Hebron University Hospital, Barcelona, Spain
The Vall d’Hebron University Hospital, founded in 1952, is one of the largest hospitals in Spain. It is comprised of four large centers: the General Area, the Maternity and Children’s Area, the Orthopaedics and Rehabilitation Area, and the Outpatient Surgery which cover almost all medical and surgical specialties. The hospital has an excellent oncology department and palliative care unit. The hospital also focuses on research-based innovations and actively runs clinical trials. The institution also conducts training for health-care professionals on a regular basis.
Website: https://www.vallhebron.com/en
About Professor Jordi Rello from Vall d'Hebron University Hospital, Barcelona, Spain
Jordi Rello is Professor of Medicine at the Universitat Internacional de Catalunya and Senior Consultant of Critical Care at the Vall d'Hebron University Hospital in Barcelona, Spain. He earned his PhD in Infectious Diseases at the University of Barcelona, Spain. His areas of research include studies on prevention and control of hospital-acquired infections, epidemiology of ventilator-associated pneumonia, gender medicine and treatment of infections in critically ill patients. He has authored 750+ research articles. He is also the Director of the Clinical Research & Innovation in Pneumonia and Sepsis (CRISP) Group at Vall d'Hebron Institute of Research.
Funding information
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-10-31
CAMBRIDGE, MA -- Cancer immunotherapy, which uses drugs that stimulate the body’s immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn’t work well for some tumors, including ovarian cancer.
To elicit a better response, MIT researchers have designed new nanoparticles that can deliver an immune-stimulating molecule called IL-12 directly to ovarian tumors. When given along with immunotherapy drugs called checkpoint inhibitors, IL-12 helps the immune system launch an attack on cancer cells.
Studying a mouse model of ovarian cancer, the researchers ...
2025-10-31
A vaccine that tackles the bacteria that cause up to 200 million childhood infections every year could be possible, experts say.
In the first study of its kind, an international team including those at the Wellcome Sanger Institute, the University of Oslo, the University of Oxford and the Shoklo Malaria Research Unit at Mahidol University in Thailand, analysed new and existing Haemophilus influenzae (H. influenzae) genomes, from global samples collected between 1962-2023. H. influenzae is a type of bacteria that can cause a range of infections that are widely treated with antibiotics, but ...
2025-10-31
Protein TDP-43 malfunctions and disrupts the normal splicing of the KCNQ2 gene
Mis-splicing of the gene causes neurons to fire too much, too easily in ALS and FTD
Study authors developed a new drug, which calmed overactive ALS neurons
CHICAGO --- A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease protein, TDP-43, drives overactive nerve cells in the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
The findings not only explain a long-standing mystery of why nerve cells overfire ...
2025-10-31
LAWRENCE — As climate change produces ever more heat waves, how many homes in the U.S. lack adequate cooling? Who’s most vulnerable to lethal temperatures, and exactly where do they live?
A researcher at the University of Kansas has produced the most comprehensive and detailed map of air conditioning usage in the United States — data that can improve the understanding of AC access for public health officials, urban planners, emergency managers, economists, energy auditors, providers of social services, private industry and other stakeholders.
The research appears today in the peer-reviewed journal Scientific ...
2025-10-31
The phrase ‘liquid metal’ may bring to mind something hazardous, like mercury or molten steel. But in the Laboratory of Photonic Materials and Fiber Devices (FIMAP) in EPFL’s School of Engineering, it simply means a mixture of indium and gallium that is nontoxic, remains liquid at room temperature, and shows great promise for developing electronic fibers for wearables and robotic sensors.
Unfortunately, as FIMAP head Fabien Sorin explains, liquid metals are extremely difficult to process, and it’s especially hard to produce electronic fibers that combine high and stable conductivity with stretchability. Now, the lab has overcome this ...
2025-10-31
A spooky bat has been spotted flying over the European Southern Observatory’s (ESO’s) Paranal site in Chile, right in time for Halloween. Thanks to its wide field of view, the VLT Survey Telescope (VST) was able to capture this large cloud of cosmic gas and dust, whose mesmerising appearance resembles the silhouette of a bat.
Located about 10 000 light-years away, this ‘cosmic bat’ is flying between the southern constellations of Circinus and Norma. Spanning an area of the sky equivalent to four full Moons, it looks as if it's trying to hunt the glowing spot above it for food.
This nebula is a stellar nursery, a vast cloud of gas and dust from ...
2025-10-31
Hydrogen peroxide (H2O2) is ranked among the top 100 most important chemicals globally. Currently, the anthraquinone oxidation method is the primary method for industrial H2O2 production, yet it faces several major issues, including complex synthesis, high energy consumption. As a more sustainable and environmentally friendly alternative, the artificial photosynthesis of H2O2 from H2O and O2 using semiconductor photocatalysts driven by renewable solar energy has attracted significant attention. A key process in this approach is the two–electron oxygen reduction reaction (2e- ORR). However, most photocatalysts face limitations, ...
2025-10-31
New research has shown for the first time that Australian marsupials are contaminated with synthetic ‘forever chemicals’, which are linked to significant health impacts in other animals and humans.
University of Melbourne researchers in the Australian Laboratory for Emerging Contaminants (ALEC) and the Melbourne Veterinary School measured the concentrations of human-made per- and polyfluoroalkyl substances (PFAS) in possums from the greater Melbourne region, with findings published today in ...
2025-10-30
How does the brain take out its trash? That is the job of the brain’s lymphatic drainage system, and efforts to understand how it works have pushed the boundaries of brain-imaging technologies.
A new study in iScience by researchers at the Medical University of South Carolina reveals, for the first time in humans, evidence of a previously unrecognized hub in the brain’s lymphatic drainage system – the middle meningeal artery (MMA). Taking advantage of a NASA partnership that provided access to real-time MRI technologies originally developed to study how spaceflight affects fluid dynamics in the human brain, the MUSC research team, ...
2025-10-30
People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer control researchers at the Medical University of South Carolina’s Hollings Cancer Center are setting out to change that.
With more than $3 million from the National Heart, Lung and Blood Institute over five years, Alana Rojewski, Ph.D., and Katherine Sterba, Ph.D., both of the department of Public Health Sciences at MUSC, will build and sustain ENHANCE-TTS (ENgaging pHarmacists to AdvANCE Tobacco Treatment Service) delivery programs that promote smoking ...
LAST 30 PRESS RELEASES:
[Press-News.org] New editorial urges clinicians to address sex-based disparities in sepsis treatment
The editorial highlights biological and gender-driven disparities shaping antibiotic dosing, therapeutic effectiveness, and outcomes in sepsis treatment
